Evidence map›Paper›PMID 34285798›Full record

ArticlePulmonary circulation

Pulmonary hypertension associated with neurofibromatosis type 2.

Hirohisa Taniguchi, Tomoya Takashima, Ly Tu, Raphaël Thuillet, Asuka Furukawa, Yoshiko Furukawa, Akio Kawamura, Marc Humbert, Christophe Guignabert, Yuichi Tamura

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pulmonary circulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Hirohisa TaniguchiDepartment of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
Tomoya TakashimaPulmonary Hypertension Centre, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
Ly TuUniversité Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.
Raphaël ThuilletUniversité Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.
Asuka FurukawaDepartment of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
Yoshiko FurukawaDepartment of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
Akio KawamuraDepartment of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
Marc HumbertUniversité Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.
Christophe GuignabertUniversité Paris-Saclay, School of Medicine, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-8545-4452
Yuichi TamuraDepartment of Cardiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4437-8019
Mita Hospital · JPInserm · FRTokyo University of Agriculture · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although precapillary pulmonary hypertension is a rare but severe complication of patients with neurofibromatosis type 1 (NF1), its association with NF2 remains unknown. Herein, we report a case of a 44-year-old woman who was initially diagnosed with idiopathic pulmonary arterial hypertension and treated with pulmonary arterial hypertension-specific combination therapy. However, a careful assessment for a relevant family history of the disease and genetic testing reveal that this patient had a mutation in the

Indexed as

endothelial dysfunctionMerlinneurofibromatosispulmonary hypertensionpulmonary vascular remodelling

Identifiers

PMID34285798
PMCPMC8264739
OpenAlexW3175388589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.